G1 Therapeutics, Inc. (NASDAQ: GTHX) Q4 2023 Earnings Call Transcript February 28, 2024 G1 Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.27. G1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback